CFLAR Antibody - N-terminal region

Artikelnummer: ASB-AVARP00022_T100
Artikelname: CFLAR Antibody - N-terminal region
Artikelnummer: ASB-AVARP00022_T100
Hersteller Artikelnummer: AVARP00022_T100
Alternativnummer: ASB-AVARP00022_T100-25UL,ASB-AVARP00022_T100-100UL
Hersteller: Aviva
Wirt: Rabbit
Kategorie: Proteine/Peptide
Applikation: WB
Spezies Reaktivität: Bovine, Canine, Equine, Human, Mouse, Rat
Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human CFLAR
Alternative Synonym: CASH, FLIP, MRIT, CLARP, FLAME, cFLIP, Casper, FLAME1, c-FLIP, FLAME-1, I-FLICE, c-FLIPL, c-FLIPR, c-FLIPS, CASP8AP1
CFLAR might contribute to the carcinogenesis and aggressiveness of endometrial carcinoma and might be a useful prognostic factor in the tumor. CFLAR is specially overexpressed in colon cancers and it might contribute to carcinogenesis of normal colonic mucosa.
Klonalität: Polyclonal
Konzentration: 1.0 mg/ml
Molekulargewicht: 55kDa
NCBI: 8837
UniProt: O15519
Formulierung: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
WB Suggested Anti-CFLAR Antibody Titration: 1.25ug/ml
Positive Control: HepG2 cell lysateCFLAR is strongly supported by BioGPS gene expression data to be expressed in Human HepG2 cells
Lanes:
Lane 1: 10ug hFLIPL transfected 293 lysate
Primary Antibody Dilution:
1:1000
Secondary Antibody:
Anti-rabbit HRP
Secondary Antibody Dilution:
1:2000
Gene Name:
CFLAR
Submitted by:
Dr. Tencho Tenev, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research
Host: Rabbit
Target Name: CFLAR
Sample Tissue: Human HepG2
Antibody Dilution: 1.0ug/ml
CFLAR antibody - N-terminal region (AVARP00022_T100) in Human 293T using Western Blot